ASIA-PACIFIC DNA SEQUENCING MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

ASIA-PACIFIC DNA SEQUENCING MARKET 2021-2028

Market by Product, Technology, Application, Industry Vertical, and Country Outlook | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research envisions the Asia-Pacific DNA sequencing market to witness growth, with a CAGR of 17.80% over the forecasting period from 2021 to 2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered in this market include:

•           China

•           Japan

•           India

•           South Korea

•           Australia & New Zealand

•           ASEAN countries

•           Rest of APAC countries

The increasing expenditure on research & development, the availability of advanced technology for drug discovery & development, and its growing adoption are positively influencing the growth of the DNA sequencing market in China. The rising R&D activities by pharma and biopharma companies are another major factor escalating the market growth. Further, with the rise in research in genomics globally, the nation is also following suit. For instance, in December 2019, Genetron Health announced that it received approval for Genetron S5, the firm’s clinical next-generation sequencing system, from the National Medical Products Association. In June 2020, the gene-sequencing company, MGI Tech, received a funding worth USD 1 billion from Citic Private Equity Funds Management and IDG Capital. A few months later, in December, Illumina Inc’s NextSeq 550Dx, received a go-ahead from the National Medical Products Administration (NMPA) of China, for genetic testing and diagnosis purposes.

On the other hand, the Japanese DNA sequencing market is also expected to thrive, thanks to factors such as the rising R&D activities and technological progress in DNA sequencing. The growing expenditure on R&D, especially in healthcare and DNA sequencing, is expected to boost the demand for DNA sequencing in Japan. For instance, in February 2020, ACTmed (Japan), Tokyo Medical and Dental University (TMDU), and ACT Genomics (Taipei, Taiwan), joined hands to conduct research, with a goal of establishing comprehensive genomic profiles of highly prevalent cancers in the country’s population.

Established in 1999, with the vision of using genomics for the benefit of humanity, BGI Genomics has become the world’s biggest genomic organization. The company lays a special focus on research and applications in the areas of healthcare, conservation, environment, and agriculture. It has a proven track record of high-profile, innovative research, being featured in more than 1,000 publications. BGI Genomics also contributes to the scientific community by publishing the international research journal GigaScience. The China-based company is headquartered in Yantian District, Shenzhen.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC DNA SEQUENCING MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE DNA SEQUENCING MARKET

2.2. KEY INSIGHTS

2.2.1. APPLICATIONS OF LIQUID BIOPSY

2.2.2. EMERGING DEVELOPING ECONOMIES

2.2.3. DEVELOPMENT IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY

2.2.4. NEXT GENERATION SEQUENCING

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. INDUSTRY COMPONENTS

2.5. KEY IMPACT ANALYSIS

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS AND PARTNERSHIPS

2.8.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

2.8.3. ACQUISITIONS & MERGERS

2.8.4. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. PREVALENCE OF CANCER CASES

2.9.2. ADVANCEMENTS IN TECHNOLOGY

2.9.3. APPLICATIONS OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION

2.10. MARKET RESTRAINTS

2.10.1. CHALLENGES ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS

2.10.2. LACK OF SKILLED PROFESSIONALS IN EMERGING ECONOMIES

2.10.3. LIMITATIONS OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING

2.11. MARKET OPPORTUNITIES

2.11.1. EXTENSIVE RESEARCH AND DEVELOPMENT IN DNA SEQUENCING

2.11.2. GROWTH IN GENOME MAPPING PROGRAMS

3. ASIA-PACIFIC DNA SEQUENCING MARKET – BY PRODUCT

3.1. INSTRUMENTS & CONSUMABLES

3.1.1. INSTRUMENTS & CONSUMABLES TYPE

3.1.1.1. CONSUMABLES

3.1.1.2. INSTRUMENTS

3.1.2. INSTRUMENTS & CONSUMABLES PLATFORM

3.1.2.1. NGS (NEXT GENERATION SEQUENCING)

3.1.2.1.1. RNA SEQUENCING

3.1.2.1.2. TARGETED RESEQUENCING

3.1.2.1.3. WHOLE-EXOME SEQUENCING

3.1.2.1.4. WHOLE-GENOME SEQUENCING

3.1.2.1.5. CHIP SEQUENCING

3.1.2.1.6. DE NOVO SEQUENCING

3.1.2.1.7. METHYL SEQUENCING

3.1.2.2. SANGER

3.2. SEQUENCING SERVICES

3.3. BIOINFORMATICS

4. ASIA-PACIFIC DNA SEQUENCING MARKET – BY TECHNOLOGY

4.1. SEQUENCING BY SYNTHESIS

4.2. ION SEMICONDUCTOR SEQUENCING

4.3. CHAIN TERMINATION SEQUENCING

4.4. PYROSEQUENCING

4.5. SEQUENCING BY LIGATION (SBL)

4.6. SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)

4.7. NANOPORE SEQUENCING

4.8. OTHER TECHNOLOGIES

5. ASIA-PACIFIC DNA SEQUENCING MARKET – BY APPLICATION

5.1. BIOMARKER DISCOVERY

5.2. DIAGNOSTICS

5.3. REPRODUCTIVE HEALTH

5.4. PERSONALIZED MEDICINE

5.5. DRUG DISCOVERY

5.6. AGRICULTURE & ANIMAL RESEARCH

5.7. FORENSICS

5.8. OTHER APPLICATIONS

6. ASIA-PACIFIC DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS

6.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES

6.2. PHARMACEUTICAL

6.3. BIOTECHNOLOGY COMPANIES

6.4. HOSPITALS & CLINICS

6.5. OTHER INDUSTRY VERTICALS

7. ASIA-PACIFIC DNA SEQUENCING MARKET – COUNTRY OUTLOOK

7.1. CHINA

7.2. JAPAN

7.3. INDIA

7.4. AUSTRALIA & NEW ZEALAND

7.5. SOUTH KOREA

7.6. ASEAN COUNTRIES

7.7. REST OF ASIA-PACIFIC

8. COMPETITIVE LANDSCAPE

8.1. ADAPTIVE BIOTECHNOLOGIES INC

8.2. AGILENT TECHNOLOGIES INC

8.3. ASURAGEN INC

8.4. BGI GENOMICS

8.5. BIO-RAD LABORATORIES INC

8.6. DANAHER CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)

8.7. EUROFINS SCIENTIFIC

8.8. F HOFFMANN-LA ROCHE

8.9. ILLUMINA INC

8.10. MERCK KGAA

8.11. PACIFIC BIOSCIENCES OF CALIFORNIA INC

8.12. PERKINELMER INC

8.13. SIEMENS HEALTHINEERS AG

8.14. SPIRAL GENETICS INC

8.15. THERMO FISHER SCIENTIFIC INC

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1. OBJECTIVES OF STUDY

9.1.2. SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1. PRIMARY DATA SOURCES

9.2.2. SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1. EVALUATION OF PROPOSED MARKET

9.3.2. IDENTIFICATION OF DATA SOURCES

9.3.3. ASSESSMENT OF MARKET DETERMINANTS

9.3.4. DATA COLLECTION

9.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       ASIA-PACIFIC DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       CONTRACTS AND PARTNERSHIPS

TABLE 4:       BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

TABLE 5:       ACQUISITIONS & MERGERS

TABLE 6:       NEW PRODUCT LAUNCHES

TABLE 7:       ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 8:       ASIA-PACIFIC INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 9:       ASIA-PACIFIC INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)

TABLE 10:     ASIA-PACIFIC NGS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 11:     ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 12:     ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 13:     ASIA-PACIFIC DNA SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

TABLE 14:     ASIA-PACIFIC DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     ASIA-PACIFIC DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING

FIGURE 3:     ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 2020 & 2028 (IN %)

FIGURE 4:     ASIA-PACIFIC DNA SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)

FIGURE 5:     ASIA-PACIFIC INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)

FIGURE 6:     ASIA-PACIFIC INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7:     ASIA-PACIFIC INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)

FIGURE 8:     ASIA-PACIFIC NGS MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 9:     ASIA-PACIFIC NGS MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 10:  ASIA-PACIFIC NGS MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 11:  ASIA-PACIFIC NGS MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 12:  ASIA-PACIFIC NGS MARKET, BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 13:  ASIA-PACIFIC NGS MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 14:  ASIA-PACIFIC NGS MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 15:  ASIA-PACIFIC INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)

FIGURE 16:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)

FIGURE 17:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)

FIGURE 18:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)

FIGURE 19:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)

FIGURE 20:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 21:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 22:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 23:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)

FIGURE 24:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028 (IN $ MILLION)

FIGURE 25:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 26:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 27:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 28:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 29:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 30:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 31:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 33:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 34:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)

FIGURE 35:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 36:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)

FIGURE 37:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 38:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)

FIGURE 39:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 40:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 41:  ASIA-PACIFIC DNA SEQUENCING MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

FIGURE 42:  CHINA DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 43:  JAPAN DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 44:  INDIA DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 45:  AUSTRALIA & NEW ZEALAND DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 46:  SOUTH KOREA DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 47:  ASEAN COUNTRIES DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 48:  REST OF ASIA-PACIFIC DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;